Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion type Assertion NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_head.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion description "[Univariate analysis of collected data demonstrated that the expressions of O(6)-MGMT and MRP-1 detected by immunohistochemistry, in addition to the consistent factors, including preoperative Karnofsky performance scale (KPS), radical surgery, and tumor location and extension, were significant prognostic factors for the overall survival (OS) of patients with glioblastoma, who received nimustine (ACNU)-based chemotherapy in association with surgery and radiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_provenance.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion evidence source_evidence_literature NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_provenance.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion SIO_000772 19019175 NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_provenance.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion wasDerivedFrom befree-20150227 NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_provenance.
- NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_assertion wasGeneratedBy ECO_0000203 NP570495.RA6TCdOz3esXRDTqPq-qgqUVtz1pl_j4hsk0FVh3bMJ_s130_provenance.